GABAPENTIN
- Product NDC
- 70518-2919
- 11-digit product format
- 705182919
- Labeler code
- 70518
- Product ID
- 70518-2919_4ab8d0dd-0947-3d29-e063-6294a90ab17a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA090007
- Marketing category
- ANDA
- Marketing start
- 2020-10-23
- Substance
- GABAPENTIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GABAPENTIN
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GABAPENTIN | 400 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6CW7F3G59X |
| Rxcui | 310432 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70518-2919-0 | GABAPENTIN | 30 in 1 BLISTER PACK | CAPSULE | 30 | | 4 |
| 70518-2919-1 | GABAPENTIN | 30 in 1 BLISTER PACK | CAPSULE | 30 | | 4 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2919-0 | 70518291900 | 30 CAPSULE in 1 BLISTER PACK (70518-2919-0) | 30 capsule | 2020-10-23 | 0000-00-00 | No | No | Current |
| 70518-2919-1 | 70518291901 | 30 CAPSULE in 1 BLISTER PACK (70518-2919-1) | 30 capsule | 2025-08-14 | | No | No | Historical |